Louis Terriou

CHU Marseille

Marseille, FR

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

CHU Marseille

Marseille, FR

Overview

Louis Terriou practices practicing medicine in Marseille, France.

Mr. Terriou is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Purpura, Splenectomy, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 172 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

CHU Marseille
Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease

Enrollment Status: Recruiting

Publish Date: March 03, 2026

Prospective, Sequential Multiple Assignment, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia

Enrollment Status: Completed

Publish Date: January 13, 2025

Intervention Type: Drug

Study Drugs: Methotrexate, Cyclophosphamide

Study Phase: Phase 2

A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma

Enrollment Status: Completed

Publish Date: March 17, 2023

Intervention Type: Drug

Study Drug: Lenalidomide and GA101

Study Phase: Phase 1/Phase 2

A Phase II Study of Efficacy and Tolerance of Azacitidine (AZA) In MDS-associated Steroid Dependent/Refractory Systemic Auto-immune and Inflammatory Disorders (SAID)

Enrollment Status: Completed

Publish Date: October 04, 2022

Intervention Type: Drug

Study Phase: Phase 2

View 3 Less Clinical Trials

172 Total Publications

The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa).

Journal: American journal of hematology

Published: May 20, 2026

View All 172 Publications

Frequently Asked Questions about Louis Terriou

Is Louis Terriou a top-rated expert for Adult Immune Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Louis Terriou is classified as an Elite expert for Adult Immune Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Louis Terriou participate in research or clinical trials?

Yes. Louis Terriou has published 172 articles and abstracts on conditions like Adult Immune Thrombocytopenia. You can view a list of Louis Terriou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Terriou's expertise for a condition

ConditionClose